This article appeared in LinkedIn Pulse on October 2, 2023 A Food and Drug Administration advisory panel’s decision to remove nasal decongestants containing phenylephrine from store shelves across the nation sent shockwaves across the healthcare spectrum.  Phenylephrine, which is in more than 250 products worth nearly $1.8 billion in sales in 2022 and is used … Continued